ARTICLE | Strategy
Profit Margin
January 11, 2010 8:00 AM UTC
Biogen Idec Inc.'s 26% profit margin for the first nine months of 2009, a measured by adjusted net income, is slightly higher than the 24% median for big pharma companies, but lower than some of the o...